Cetrelimab (anti-PDCD1) - 1차 항체, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor, INHIBITOR of Programmed cell death protein 1 inhibitor

CAS: 2050478-92-5 Cat. No.: Ab179071
주문 가능
GRADE & PURITY Animal Free ? Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material. Carrier Free ? Carrier-free — supplied without added carrier protein/stabilizer. Use when carriers (e.g. BSA) would interfere with conjugation or sensitive assays. Recombinant ? Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin. ExactAb™ ? ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications. Low Endotoxin ? Low-endotoxin grade — endotoxin reduced to low controlled levels. Use in sensitive biological work where high endotoxin would interfere. Azide Free ? Azide-free — without sodium azide preservative. Use in conjugations, cell work, or assays where azide is toxic or inhibitory. Validated ? Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated. ≥95%(SDS-PAGE&SEC-HPLC) See COA
Application
Animal Model, ELISA, Flow Cytometry, Functional Assay
Host species
인간
Reactive species
원숭이, 인간
Isotype
Human IgG4SP
Conjugation
Unconjugated
★
Size
USA
독일 (EU)*
Price
Qty
100μg
Ab179071-100μg
재고 있음 ≥10
—
US$91.90
1mg
Ab179071-1mg
4 재고 있음
—
US$571.90
5mg
Ab179071-5mg
1 재고 있음
—
US$1,333.90
10mg
Ab179071-10mg
US 주문제작 · 2–4주 ·
—
US$2,137.90
Enter a quantity for the sizes you want to add.
🧪
Why this grade

Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

개요

Cetrelimab (anti-PDCD1) is a humanized mAb targeting PD-1. Cetrelimab (anti-PDCD1) binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab (anti-PDCD1) stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Specifications

Product Name
Cetrelimab (anti-PDCD1) - 1차 항체, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
동의어
CD279 antibody | CD279 antigen antibody | hPD 1 antibody | hPD l antibody | hPD-1 antibody | hSLE1 antibody | PD 1 antibody | PD-1 antibody | PD1 antibody | PDCD 1 antibody | PDCD1 antibody | PDCD1_HUMAN antibody | Programmed cell death 1 antibody | Progr
사양 및 순도
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
숙주 종
인간
특이성
PDCD1
변화
Unconjugated
등급
Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
작업 유형
INHIBITOR
작동 메커니즘
INHIBITOR of Programmed cell death protein 1 inhibitor
아이소타입
Human IgG4SP
라이트 체인 유형
kappa
SDS-PAGE
26.7 kDa (Light Chain) & 53.2 kDa (Heavy Chain), under reducing conditions; 180.0 kDa, under non-reducing conditions.
정화 방법
Protein A purified
순도
>95%
집중력
See COA
CAS
2050478-92-5
Product Line
생물 제품
보관 및 배송
모양
Liquid
보관 조건
Store at -80°C,Avoid repeated freezing and thawing
배송
Dry ice packs + Cold packs
안정성 및 스토리지
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
이미지

Cetrelimab (anti-PDCD1) (Ab179071) - Flow Cytometry
Flow Cytometry analysis of 500 ng/mL Ionomycin (I139530) and 10 ng/mL PMA (P408905) co-stimulated MOLT-4 cells (24h) labelling PDCD1 (red) with Cetrelimab (anti-PDCD1) (Ab179071). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.


Cetrelimab (anti-PDCD1) (Ab179071) - SEC
The purity of Cetrelimab (anti-PDCD1) (Ab179071) is more than 95% verified by HPLC.

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

관련 대상(인간)
PDCD1 Tclin Programmed cell death protein 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDCD1 Tclin Programmed cell death protein 1 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
작용 메커니즘
인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot NumberCertificate Type날짜항목
ZJ24F1114049Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F1114050Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F1114051Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F0404224Certificate of AnalysisFeb 11, 2026 Ab179071
ZJ24F0404225Certificate of AnalysisFeb 11, 2026 Ab179071
ZJ24F0404226Certificate of AnalysisFeb 11, 2026 Ab179071
솔루션 계산기
리뷰

고객 리뷰

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →

관련 상품

Camrelizumab (anti-PD-1) - 1차 항체, for Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Cemiplimab (anti-PD-1) - 1차 항체, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, Human IgG4, Antibody of programmed cell death 1 (CD279)
Nivolumab (anti-PD-1) - 1차 항체, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1/PD-1/CD279, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Pembrolizumab (anti-PD-1) - 1차 항체, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Mouse Anti-Human IgM Antibody - 2차 항체, for ELISA various applications, from Human, generated in Mouse, IgG1
Mouse Anti-Human IgG H&L (HRP) - 2차 항체, for ELISA various applications, from Human, generated in Mouse, IgG1
Goat Anti-Human IgG H&L (HRP) - 2차 항체, for WB,ELISA,IHC various applications, from Human, generated in Goat, IgG
Mouse Anti-Human IgG Antibody - 2차 항체, for ELISA,CLIA various applications, from Human, generated in Rat, IgG1
Human IgG - 아이소타입 대조 항체, for WB,CLIA,LF,EIA,PRTIA various applications, generated in Human, >95%, IgG
Spartalizumab (anti-PD-1) - 1차 항체, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Penpulimab (anti-PDCD1) - 1차 항체, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG1, Antibody of programmed cell death 1 (CD279)
Sintilimab (anti-PD-1) - 1차 항체, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Dostarlimab (anti-PD-1) - 1차 항체, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Pidilizumab (anti-PD-1) - 1차 항체, specific to PDCD1, Human IgG1, INHIBITOR of Programmed cell death protein 1 inhibitor
Retifanlimab (anti-PD-1) - 1차 항체, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Zimberelimab (anti-PD-1) - 1차 항체, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Tislelizumab (anti-PDCD1) - 1차 항체, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
Goat Anti-Human IgG Antibody - 2차 항체, ≥ 95%
Mouse Anti-Human IgA H&L Antibody - 2차 항체, Mouse IgG1
Goat Anti-Human IgG (HRP) - 2차 항체
Goat Anti-Human IgG (Biotin) - 2차 항체
PD1 Mouse mAb - 1차 항체, specific to PD1, Mouse IgG1
Goat Anti-Human IgG (Cy5) - 2차 항체
Goat Anti-Human IgG (APC) - 2차 항체
Goat Anti-Human IgG (PE) - 2차 항체
Goat Anti-Human IgG (TRITC) - 2차 항체
Goat Anti-Human IgG (FITC) - 2차 항체
Serplulimab (anti-PDCD1) - 1차 항체, specific to PDCD1, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Mouse Anti-Human IgE epsilon chain Antibody - 2차 항체
Geptanolimab (anti-PDCD1) - 1차 항체, specific to PDCD1, >95%, Human IgG4SP
Goat Anti-Human IgG Fc Antibody - 2차 항체, Goat IgG
Budigalimab (anti-PD-1) - 1차 항체, specific to PDCD1, Human IgG1, INHIBITOR of Programmed cell death protein 1 inhibitor
Sasanlimab (anti-PD-1) - 1차 항체, specific to PDCD1, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Balstilimab (anti-PD-1) - 1차 항체, specific to PDCD1, Human IgG4SP-Opti, ANTAGONIST of Programmed cell death protein 1 antagonist
Pimivalimab (anti-PD-1) - 1차 항체, specific to PDCD1, >95% (SDS-PAGE&SEC), Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
Ezabenlimab (anti-PD-1) - 1차 항체, specific to PDCD1, >95% (SDS-PAGE&SEC), Human IgG4SP
Toripalimab (anti-PD-1) - 1차 항체, specific to PDCD1, Human IgG1, ANTAGONIST of Programmed cell death protein 1 antagonist
Human IgG2-Kappa - 아이소타입 대조 항체, Human IgG2
Human IgG3-kappa - 아이소타입 대조 항체, Human IgG3
Finotonlimab (anti-PD-1) - 1차 항체, specific to PDCD1, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
PD1 Mouse mAb (FITC) - 1차 항체, specific to PD1, Mouse IgG1
PD1 Mouse mAb (PE) - 1차 항체, specific to PD1, Mouse IgG1
PD1 Mouse mAb (APC) - 1차 항체, specific to PD1, Mouse IgG1
PD1 Mouse mAb (Biotin) - 1차 항체, specific to PD1, Mouse IgG1
Peresolimab (anti-PD-1) - 1차 항체, specific to PDCD1, Human IgG1
Rosnilimab (anti-PD-1) - 1차 항체, specific to PDCD1, Human IgG1
PD1/CD279 Mouse mAb - 1차 항체, specific to PD1/CD279, Mouse IgG1
Human IgG1-kappa, anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD, Human IgG1
Human IgG4-kappa - 아이소타입 대조 항체, IgG4
Goat Anti-Human IgG (AF647) - 2차 항체, IgG
Goat Anti-Human IgG (AF405) - 2차 항체, IgG
Human IgG (FITC) - 아이소타입 대조 항체, IgG
Human IgG (APC) - 아이소타입 대조 항체, IgG
Human IgG (PE) - 아이소타입 대조 항체, IgG
Human IgG1(P331S/E430G)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(P331S/E430G)
Human IgG1(D265A/N297A)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(D265A/N297A)
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(K409R/E356D/M358L)
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(P329G/E356D/M358L)
Human IgG1(F405L)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(F405L)
Human IgG1(N297Q)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(N297Q)
Human IgG (Biotin) - 아이소타입 대조 항체, IgG
Human IgG1(N297S)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(N297S)
Human IgG1(E233A/L235A)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(E233A/L235A)
Human IgG1(K214R/N297A)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(K214R/N297A)
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(K214R/L234A/L235A)
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(N297A/E356D/M358L)
Human IgG1(L234F/L235E)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(L234F/L235E)
Human IgG1(D265A)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(D265A)
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(K214R/L234F/L235E/P331S)
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(K214R/E356D/M358L)
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(L234A/L235A/G237A)
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(L234A/L235A/F405L)
Human IgG1(D270N)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(D270N)
Human IgG4(S228P)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG4(S228P)
Human IgG1(N297A)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG1(N297A)
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL - 아이소타입 대조 항체, specific to HEL, Human IgG4(S228P/L235E/P329G)
Human IgG1-lambda1, anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD, Human IgG1
Human IgG1-lambda2, anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD, Human IgG1
Iparomlimab (anti-PDCD1) - 1차 항체, specific to PDCD1, Human IgG4SP
Prolgolimab (anti-PDCD1) - 1차 항체, specific to PDCD1, Human IgG1
Nofazinlimab (anti-PDCD1) - 1차 항체, specific to PDCD1, Human IgG4SP
Rulonilimab (anti-PDCD1) - 1차 항체, specific to PDCD1, Human IgG1
Goat Anti-Human IgG (AF555) - 2차 항체, IgG
Human IgG1-kappa (AF405), anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD
Human IgG1-kappa (AF647), anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD
Human IgG1-kappa (APC), anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD
Human IgG1-kappa (Biotin), anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD
Human IgG1-kappa (AF700), anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD
Human IgG1-kappa (FITC), anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD
Human IgG1-kappa (AF555), anti-Spike RBD - 아이소타입 대조 항체, specific to Spike RBD
Centrose patent anti-dysadherin (anti-Dysadherin) - 1차 항체, specific to FXYD5
Human IgG (AF647) - 아이소타입 대조 항체
Human IgG (AF488) - 아이소타입 대조 항체
Human IgG (AF700) - 아이소타입 대조 항체
Human IgG (AF405) - 아이소타입 대조 항체
Goat Anti-Human IgG (AF488) - 2차 항체
Goat Anti-Human IgG Fc (Cy5) - 2차 항체
Goat Anti-Human IgG Fc (AF555) - 2차 항체, specific to Human IgG Fc
Goat Anti-Human IgG Fc (TRITC) - 2차 항체
Goat Anti-Human IgG Fc (AF700) - 2차 항체, specific to Human IgG Fc
Goat Anti-Human IgG Fc (AF405) - 2차 항체
Goat Anti-Human IgG Fc (Biotin) - 2차 항체, specific to Human IgG Fc
Goat Anti-Human IgG Fc (AF647) - 2차 항체
Goat Anti-Human IgG Fc (FITC) - 2차 항체, specific to Human IgG Fc
Human IgG (AF555) - 아이소타입 대조 항체

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.